Heat Biologics (HTBX) known for its oncology research has now joined the race to develop a COVID vaccine. As a result, its stock price is up by more than 500% since March when the medical research firm announced COVID-19-related developments.
Figure 1: HTBX price evolution
Data by YCharts
Now, gone are the days when small biotechs like Moderna (MRNA) would announce vaccine-related news and benefit from a "first-mover" advantage in terms of investors’ interest. The COVID vaccine development space is now crowded and some may wonder whether all the news are just a means to